跳至主要内容
临床试验/ISRCTN08013636
ISRCTN08013636已完成不适用

A randomised prospective study to investigate the efficacy of corneal collagen cross linkage with riboflavin (vitamin B2) and ultraviolet A light (UVA) (370nm) to halt the progression of keratoconus

Record Provided by the NHSTCT Register - 2007 Update - Department of Health0 个研究点目标入组 36 人开始时间: 2007年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 36 patients with moderate bilateral keratoconus recruited from the corneal and contact lens clinics at Guy's and St. Thomas' NHS Foundation Trust.
  • 1. Age 18 to 70
  • 2. Must fully understand the investigative nature of the study
  • 3. Moderate to advanced bilateral keratoconus
  • 4. No known allergies to pre- and post-operative medications
  • Willingness to attend for follow-up examinations

排除标准

  • 1. Age below 18
  • 2. Other pre-existing ophthalmic pathology
  • 3. Previous ophthalmic surgery
  • 4. Unilateral keratoconus
  • 5. Severe keratoconus in which the cornea is so distorted that accurate refractive and corneal measurements cannot be obtained (in these eyes data confirming stability or progression is not possible)

研究者

发起方
Record Provided by the NHSTCT Register - 2007 Update - Department of Health

相似试验